Christian Behrenbruch
MD & Group CEO, Director · Telix Pharmaceuticals Ltd
- 2026
- May 7, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christian Behrenbruch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Darren Charlton Smith - $20K in TLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christian Behrenbruch?
Christian Behrenbruch is a corporate insider, tracked as MD & Group CEO, Director of Telix Pharmaceuticals Ltd (TLX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christian Behrenbruch last file a Form 4?
The only primary Form 4 on record is dated 7 May 2026.
Has Christian Behrenbruch been buying or selling stock?
Recorded transactions: 2 open-market purchases ($997K) and 0 open-market sales across all tracked filings.
